TRIB
Trinity Biotech Plc
NASDAQ · Healthcare · Medical - Diagnostics & Research · IE
$6.43
−2.02%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.54x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.07x
- Price / sales
- 0.12x
- Price / cash flow
- -0.84x
Enterprise value
- Enterprise value
- $138.1M
- EV / sales
- 3.15x
- EV / EBITDA
- -16.12x
- EV / EBIT
- -12.27x
- Market cap
- $5.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Dec 1, 2025